The analysis workflow starts with the analysis of the FBN1 gene detectable in 70–90% of MFS patients [11, 35–37], and then, in the case of negative result, it is extended to TGFBR2 and TGFBR1 gene. This evidence concerns the gene FBN1 and Marfan syndrome.